Back to CVE records
Medium 5.2Published Aug 13, 2026

CVE-2026-0298GlobalProtect App: Code Execution Vulnerability in Windows Pre-Logon Access Provider (PLAP)

Updated under an hour ago ()

Does this affect you?

It affects Palo Alto Networks GlobalProtect App and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

An improper input validation vulnerability exists in the Windows Pre-Logon Access Provider (PLAP) component of the Palo Alto Networks GlobalProtect™ app on Windows devices which enables a man-in-the-middle (MitM) attacker to execute arbitrary code with SYSTEM privileges on an affected client. The GlobalProtect app on Linux, macOS, iOS, Android, and Chrome OS is not affected.

CVSS
5.2 MEDIUM (v4.0, CNA)CVSS:4.0/AV:A/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:L/SI:N/SA:N/E:U/AU:N/R:U/V:D/RE:M/U:Amber
Weakness (CWE)
CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
palo_alto
NVD analysis
Undergoing Analysis
Record last updated
Aug 13, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Palo Alto Networks GlobalProtect App
palo_alto_networks:globalprotect_app
from 6.3.0 before 6.3.3-h14; fixed at 6.3.3-h14; from 6.2.0 before 6.2.8-h13; fixed at 6.2.8-h13; from 6.0.0 before 6.0.15; fixed at 6.0.15
CNA record
paloaltonetworks globalprotect
paloaltonetworks:globalprotect
from 6.0.0 before 6.0.15; from 6.2.0 before 6.2.8; from 6.3.0 before 6.3.3; 6.0.15; 6.2.8; 6.2.8; 6.2.8; 6.2.8; and 19 more ranges
NVD

References

  • vendor-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.